Using Data Mining to Characterize DNA Mutations by Patient Clinical Features

Journal of the American Medical Informatics Association

Volumn 4, Issue SUPPL., 1997, Pages 253-257

  Evans, Steven ^a,b   Lemon, Stephen J ^a   Deters, Carolyn ^b   Fusaro, Ramon M ^a   Durham, Carolyn ^a   Snyder, Carrie ^a   Lynch, Henry T ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Oncormed Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0346580218     PISSN: 10675027     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Lynch HT. Cancer and the family history trail. NYState Jour of Med April, 1985; 145-7.
2. Lynch HT, Fitzgibbons RJ Jr, and Lynch JF. Heterogeneity and natural history of breast cancer. Surg Clin Of NA 1990; 70:753-74.
3. Wooster R, Neuhausen SL, Mangion J, et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994; 265:2088-90.
4. Fishel R, Lescoe MK, Rao MRS, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993; 75:1027-38.
5. Bronner CE, Baker SM, Morrison PT, et al. Mutations in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 1994; 368: 258-61.
6. Shattuck-Eidens D, McClure M, Simard J, et al. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: implications for presymptomatic testing and screening. JAMA 1995; 273:535.
7. Gayther SA, Warren W, Mazoyer S, et al. Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nature Genet 1995; 11:428-33.
8. Serova O, Montagna M, Torchard D, et al. A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families. Am J Hum Genet 1996; 58:42-51.
9. Pawlak Z. Rough Sets: Theoretical aspects of reasoning about data. Dordrecht, The Netherlands: Kluwer Academic Publishers., 1991.
10. Slowinski R. Intelligent decision support: handbook of applications and advances of the rough sets theory. Dordrecht, The Netherlands: Kluwer Academic Publishers, 1992.
11. Schneider KA. Counseling about cancer. Boston, MA: Dana-Farber Cancer Institute, 1994.
12. Lynch HT, Hirayama T. Genetic epidemiology of cancer. Boca Raton: CRC Press, 1989.
13. Struewing JP, Abeliovich D, Peretz T, et al. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nature Genet 1995; 11:198-200.
14. Evans S, inventor. Methods for identifying human hereditary disease patterns. US patent 5642936, 1997, July 1.
15. Rubin SC, Benjamin I, Behbakht K, et al. Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. N Engl J Med 1996; 335:1413.
16. Wu Y, Giger ML, Doi K, et al. Artificial neural networks in mammography: application to decision making in the diagnosis of breast cancer. Radiology 1993; 187: 81-87.
17. Hassoun MH. Fundamentals of artificial neural networks. Cambridge, MA: MIT Press, 1995.
18. Liebowitz J. Introduction to expert systems. Santa Cruz, CA: Mitchell Publishing, 1988.
19. Cancer Statistics 1996. Cancer 1996; 46: 8.